Literature DB >> 21865299

Functional and physical interaction between the mismatch repair and FA-BRCA pathways.

Stacy A Williams1, James B Wilson, Allison P Clark, Alyssa Mitson-Salazar, Andrei Tomashevski, Sahana Ananth, Peter M Glazer, O John Semmes, Allen E Bale, Nigel J Jones, Gary M Kupfer.   

Abstract

Fanconi anemia (FA) is a rare genetic disorder characterized by bone marrow failure and an increased risk for leukemia and cancer. Fifteen proteins thought to function in the repair of DNA interstrand crosslinks (ICLs) comprise what is known as the FA-BRCA pathway. Activation of this pathway leads to the monoubiquitylation and chromatin localization of FANCD2 and FANCI. It has previously been shown that FANCJ interacts with the mismatch repair (MMR) complex MutLα. Here we show that FANCD2 interacts with the MMR proteins MSH2 and MLH1. FANCD2 monoubiquitylation, foci formation and chromatin loading are greatly diminished in MSH2-deficient cells. Human or mouse cells lacking MSH2 or MLH1 display increased sensitivity and radial formation in response to treatment with DNA crosslinking agents. Studies in human cell lines and Drosophila mutants suggest an epistatic relationship between FANCD2, MSH2 and MLH1 with regard to ICL repair. Surprisingly, the interaction between MSH2 and MLH1 is compromised in multiple FA cell lines, and FA cell lines exhibit deficient MMR. These results suggest a significant role for MMR proteins in the activation of the FA pathway and repair of ICLs. In addition, we provide the first evidence for a defect in MMR in FA cell lines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865299      PMCID: PMC3196888          DOI: 10.1093/hmg/ddr366

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  71 in total

1.  A naturally occurring hPMS2 mutation can confer a dominant negative mutator phenotype.

Authors:  N C Nicolaides; S J Littman; P Modrich; K W Kinzler; B Vogelstein
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

2.  Loss of DNA mismatch repair in acquired resistance to cisplatin.

Authors:  S Aebi; B Kurdi-Haidar; R Gordon; B Cenni; H Zheng; D Fink; R D Christen; C R Boland; M Koi; R Fishel; S B Howell
Journal:  Cancer Res       Date:  1996-07-01       Impact factor: 12.701

3.  The role of DNA mismatch repair in platinum drug resistance.

Authors:  D Fink; S Nebel; S Aebi; H Zheng; B Cenni; A Nehmé; R D Christen; S B Howell
Journal:  Cancer Res       Date:  1996-11-01       Impact factor: 12.701

4.  Selective recognition of a cisplatin-DNA adduct by human mismatch repair proteins.

Authors:  M Yamada; E O'Regan; R Brown; P Karran
Journal:  Nucleic Acids Res       Date:  1997-02-01       Impact factor: 16.971

5.  MSH3 deficiency is not sufficient for a mutator phenotype in Chinese hamster ovary cells.

Authors:  J M Hinz; M Meuth
Journal:  Carcinogenesis       Date:  1999-02       Impact factor: 4.944

6.  Genetic analysis of mitomycin C-hypersensitive Chinese hamster cell mutants.

Authors:  N J Jones
Journal:  Mutagenesis       Date:  1994-09       Impact factor: 3.000

7.  Neurofibromatosis and early onset of cancers in hMLH1-deficient children.

Authors:  Q Wang; C Lasset; F Desseigne; D Frappaz; C Bergeron; C Navarro; E Ruano; A Puisieux
Journal:  Cancer Res       Date:  1999-01-15       Impact factor: 12.701

8.  Isolation of MutSbeta from human cells and comparison of the mismatch repair specificities of MutSbeta and MutSalpha.

Authors:  J Genschel; S J Littman; J T Drummond; P Modrich
Journal:  J Biol Chem       Date:  1998-07-31       Impact factor: 5.157

9.  Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase.

Authors:  T Xu; W Wang; S Zhang; R A Stewart; W Yu
Journal:  Development       Date:  1995-04       Impact factor: 6.868

10.  Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.

Authors:  A H Brand; N Perrimon
Journal:  Development       Date:  1993-06       Impact factor: 6.868

View more
  27 in total

Review 1.  Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway.

Authors:  Hyungjin Kim; Alan D D'Andrea
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

Review 2.  The differences between ICL repair during and outside of S phase.

Authors:  Hannah L Williams; Max E Gottesman; Jean Gautier
Journal:  Trends Biochem Sci       Date:  2013-07-03       Impact factor: 13.807

3.  A novel role for non-ubiquitinated FANCD2 in response to hydroxyurea-induced DNA damage.

Authors:  X Chen; L Bosques; P Sung; G M Kupfer
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

Review 4.  Stress and DNA repair biology of the Fanconi anemia pathway.

Authors:  Simonne Longerich; Jian Li; Yong Xiong; Patrick Sung; Gary M Kupfer
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

Review 5.  Current update on the molecular genetics and management of hereditary ovarian cancers: a primer for radiologists.

Authors:  Malak Itani; Neeraj Lalwani; Dhakshinamoorthy Ganeshan; Maria Zulfiqar; Cary Siegel
Journal:  Abdom Radiol (NY)       Date:  2021-04-13

Review 6.  Fanconi anaemia and the repair of Watson and Crick DNA crosslinks.

Authors:  Molly C Kottemann; Agata Smogorzewska
Journal:  Nature       Date:  2013-01-17       Impact factor: 49.962

Review 7.  What is wrong with Fanconi anemia cells?

Authors:  Sharon B Cantor; Robert M Brosh
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  Lysine Acetylation and Succinylation in HeLa Cells and their Essential Roles in Response to UV-induced Stress.

Authors:  Hong Xu; Xuanyi Chen; Xiaoli Xu; Rongyi Shi; Shasha Suo; Kaiying Cheng; Zhiguo Zheng; Meixia Wang; Liangyan Wang; Ye Zhao; Bing Tian; Yuejin Hua
Journal:  Sci Rep       Date:  2016-07-25       Impact factor: 4.379

Review 9.  Structural, molecular and cellular functions of MSH2 and MSH6 during DNA mismatch repair, damage signaling and other noncanonical activities.

Authors:  Michael A Edelbrock; Saravanan Kaliyaperumal; Kandace J Williams
Journal:  Mutat Res       Date:  2013-02-04       Impact factor: 2.433

Review 10.  Development of primary early-onset colorectal cancers due to biallelic mutations of the FANCD1/BRCA2 gene.

Authors:  Emilie Degrolard-Courcet; Joanna Sokolowska; Marie-Martine Padeano; Séverine Guiu; Myriam Bronner; Carole Chery; Fanny Coron; Côme Lepage; Caroline Chapusot; Catherine Loustalot; Jean-Louis Jouve; Cyril Hatem; Emmanuelle Ferrant; Laurent Martin; Charles Coutant; Amandine Baurand; Gérard Couillault; Alexandra Delignette; Salima El Chehadeh; Sarab Lizard; Laurent Arnould; Pierre Fumoleau; Patrick Callier; Francine Mugneret; Christophe Philippe; Thierry Frebourg; Philippe Jonveaux; Laurence Faivre
Journal:  Eur J Hum Genet       Date:  2013-12-04       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.